Tune in to hear all about the company’s achievements over the past 12 months. Recce Pharmaceuticals is a Stockhead client at the time of publishing. The discussion in this video is opinion only and ...

ZEE5 is not just an OTT platform. It’s more than that. It has always been dishing out the best in terms of content. Its content has touched millions of hearts. Without limiting itself to a genre, ZEE5 ...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully looks at the latest from Recce Pharmaceuticals (ASX:RCE), which has secured an ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

A federal ‘advanced overseas finding’ means Recce can claim up to $85 million in R&D tax offsets Radiopharm is ‘grossly mispriced’, says Bell Potter Entropy Neurodynamics treats first patient in binge ...